Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept.

@article{Buch2007TherapyOP,
  title={Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept.},
  author={M H Buch and Sarah J. Bingham and Victoria Bejarano and Domini Jayne Bryer and Jo White and Richard Reece and Mark Quinn and Paul Emery},
  journal={Arthritis and rheumatism},
  year={2007},
  volume={57 3},
  pages={448-53}
}
OBJECTIVE The role of alternative tumor necrosis factor (TNF) antagonist therapies in the context of failure of initial TNF antagonist therapy in patients with rheumatoid arthritis (RA) has yet to be clearly defined. The goal of this study was to determine the efficacy of etanercept in patients who failed to respond to infliximab. METHODS Ninety-five patients with RA who failed to respond to infliximab and methotrexate were treated with etanercept (with continuation of concomitant… CONTINUE READING